Towards real-time intraoperative tissue interrogation for REIMS-guided glioma surgery

Laura Van Hese1,2, Steven De Vleeschouwer3, Tom Theys3

  • 1Maastricht MultiModal Molecular Imaging (M4I) Institute, Division of Imaging Mass Spectrometry, Maastricht University, 6229 ER Maastricht, The Netherlands.

Abstract

Insights

This study introduces a mass spectrometry technique to rapidly identify glioma tissue during surgery. The rapid evaporative ionization mass spectrometry (REIMS) system accurately differentiates various glioma subtypes, improving surgical precision.

Area of Science:

  • Neuro-oncology
  • Analytical Chemistry
  • Machine Learning

Background:

  • Accurate tissue characterization and margin delineation are crucial for optimal brain tumor surgery outcomes.
  • Maximizing tumor resection while preserving neurological function is the primary surgical goal.

Purpose of the Study:

  • To develop and validate a mass spectrometry-based technique for molecular characterization of high- and low-grade glioma tissue during surgery.
  • To enable real-time tissue recognition for improved intra-operative decision-making.

Main Methods:

  • Utilized an electrosurgical knife connected to a mass spectrometer (iKnife) for rapid evaporative ionization mass spectrometry (REIMS).
  • Aerosolized tissue during resection was aspirated for immediate molecular profiling.
  • Developed a machine learning-based real-time tissue recognition system using a chemical profile database.

Main Results:

  • The REIMS technique achieved 88% overall accuracy in differentiating glioma subtypes (astrocytoma II/III, glioblastoma, oligodendroglioma II/III) and normal brain tissue.
  • Achieved 96% accuracy in separating astrocytoma and oligodendroglioma grade II from normal brain tissue.
  • Demonstrated high sensitivity in differentiating GBM (99.2%) and astrocytoma grade II (97.5%).

Conclusions:

  • Real-time molecular information during electrosurgical dissection enhances intra-operative decision-making.
  • This technique can lead to more accurate tumor removal for various glioma subtypes.
  • The REIMS system shows promise for improving surgical outcomes in neuro-oncology.

Related Concept Videos